Valisure’s mission is to bring transparency and increased quality to the pharmaceutical industry, and to deliver these benefits direct to consumers. We hope to achieve this through focusing on patient advocacy, consumer protection, and performing advanced research and development.
Friends since their Yale days
Founders Adam Clark-Joseph and David Light reconnected after Adam suffered serious complications caused by batch variability of his anticonvulsant medication. Upon further research, they began to grasp the magnitude and pervasiveness of the problem throughout the pharmaceutical industry. Adam and David brought together a team of like-minded scientists and pharmacy experts to develop and deploy a solution. The result was Valisure, a company dedicated to preventing anyone from suffering adverse effects from low quality medications.
Meet the Team
See what is being said about Valisure today
David Light Founder and CEO
David is a biotech entrepreneur and scientist with over 10 years of broad experience in the field. A graduate of Yale University, David studied molecular biology and has worked in a variety of scientific and business roles at start-ups like Synthetic Genomics, 454 Life Sciences and Ion Torrent. At Ion, David developed key technologies that led to its $725M acquisition and ran its flagship technology programs through development and global commercialization.
Kaury Kucera, PHD Chief Scientific Officer
Kaury has managed scientific challenges at Yale University as a Molecular Biophysics and Biochemistry Graduate Student, Postdoctoral Fellow, and Research Scientist in the Department of Pharmacology. A scientist and problem-solver, Kaury was the research director for a $2.5M HHMI matched grant program and personally oversaw development of 200+ unique assays to investigate bioactive molecules.
Paul Barry, MBA, RPH Chief Pharmacist
Paul has 30+ years diverse experience in operations and finance of retail and wholesale pharmacy both at the local and national level. Paul has a BS in pharmacy from the Massachusetts College of Pharmacy and a Master of Business Administration from Rensselaer Polytechnic Institute. Paul is a Registered Pharmacist in the state of Connecticut.
David Gortler, PharmD, FDDP Chief Medical Officer
Dr. David Gortler is a professor of pharmacology, a former FDA medical officer/senior medical analyst and an expert in the area of drug safety, FDA policy, and drug importation. Dr. Gortler has been invited to testify in front of the U.S. Senate as a drug policy expert, FDA expert and pharmacology expert. He has two decades of investigational medicine and drug safety experience, and over a decade of teaching and research at top-tiered medical schools (Yale University, Georgetown University, and George Washington University).
Daniel Berkal Chief Marketing Officer
Daniel has managed marketing challenges with extensive experience on both the agency and the vendor side. He has hands-on experience leading work on world class brands like Nike, Facebook, Coca-Cola, Amazon, and many others in North America, Central America, Europe and Asia. Daniel is SVP at The Palmerston Group, a regular instructor at Miami Ad School and a frequent speaker at industry conferences. Daniel holds a BA in psychology from McGill University and a masters in advertising from The University of Texas at Austin.
Adam Clark-Joseph, PhD Founder
Adam is an assistant professor of finance at the University of Illinois at Urbana-Champaign. He holds a PhD in economics from Harvard, a master’s degree from Cambridge, and bachelor’s degrees in math and economics from Yale. Adam was the recipient of a NSF Graduate Research Fellowship and a Gates Cambridge Scholarship. His academic research focuses on algorithmic trading, and empirical applications of high-performance computing and novel statistical methods.
Robert Cunningham Founder
Bob is Director of Platform Development at Harvard University, responsible for the implementation of commercialization and technology translation strategies. His industry experience with Haemonetics, endoVia Medical, RainDance Technologies, and Hemocell includes founder, CEO and other executive roles in companies commercializing innovative technologies. He holds a degree in Biochemistry from the University of California at San Diego and is a member of the Massachusetts Biotechnology Industry Council.
Wolfgang Hinz Founder
Wolfgang is a senior director in the Clinical Sequencing Division of Thermo Fisher Scientific with over 16 years of experience in technology development. A graduate of the University of Cape Town, Wolfgang conducted research as a postdoctoral fellow at Yale University in Physical Organic Chemistry and Pharmacology. Wolfgang is passionate about the use of technology to solve problems in public health and is named inventor on 30+ granted patents and 70+ patent applications.
Amber Jessop, MSc Data Scientist
Amber is a data scientist and former adjunct instructor of physics. She holds a Masters of Science from Yale University and two Bachelor’s degrees, in Applied Mathematics and in Physics from the University of Montana. As a research assistant in Montana, Amber modeled and analyzed data obtained by an ion mass spectrometer as it flew through the coma of comet 19P/Borrelly. Her research at Yale was in computational biology and bioinformatics, where she modeled high resolution protein and crystal structures as well as in molecular biophysics and biochemistry, where she used conductive atomic force microscopy to measure electron transfer in bacteria pili.
Nicola Zenzola Heimbach, MSc Senior Research Associate
Nicola is a Research Associate in the field of biopharma who holds a Professional Science Master’s in biotechnology from the University of South Florida and a Bachelor of Science degree in marine science with a biology focus, from Eckerd College. His research focused on investigating the bioactivity of collagen peptides extracted from cod skin on murine chondrocyte cell mineralization.
Nicola has also contributed to research projects involving stable isotopes and chemical fingerprinting investigations, examining the impacts caused by oil spills on fish and the benthic environment as recorded in deep sea sediment.
Daniel O'Neill Lab Manager/Research Associate
Dan is an experienced Research Associate with six years of DNA sequencing at the Rothberg Institute for Childhood Diseases. During his time at The Rothberg Institute he worked on a wide variety of projects from cell culture, to DNA and RNA extraction and sequencing with Ion Torrent systems. He also trained new staff and managed the equipment and supplies for the lab. A Western Connecticut grad, he has worked in a variety of fields outside of science and has brought a wide spectrum of knowledge to his tasks.
Jessica Williston, MA Senior Operations Manager/Pharmacy Technician
Jessica has worked as a Human Resources Assistant at Securitas Security Services USA, Inc. for 7 years, where she conducted candidate interviews, on-boarded personnel, and administered the day-to-day operations of the office. She holds a Master’s Degree in education and a Bachelor’s Degree in media studies, both of which are from Sacred Heart University. For the past 4 years Jessica has taught English at a local high school.